241 related articles for article (PubMed ID: 16101743)
1. Dietary n-3 polyunsaturated fatty acid depletion activates caspases and decreases NMDA receptors in the brain of a transgenic mouse model of Alzheimer's disease.
Calon F; Lim GP; Morihara T; Yang F; Ubeda O; Salem N; Frautschy SA; Cole GM
Eur J Neurosci; 2005 Aug; 22(3):617-26. PubMed ID: 16101743
[TBL] [Abstract][Full Text] [Related]
2. A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model.
Lim GP; Calon F; Morihara T; Yang F; Teter B; Ubeda O; Salem N; Frautschy SA; Cole GM
J Neurosci; 2005 Mar; 25(12):3032-40. PubMed ID: 15788759
[TBL] [Abstract][Full Text] [Related]
3. Docosahexaenoic acid protects from dendritic pathology in an Alzheimer's disease mouse model.
Calon F; Lim GP; Yang F; Morihara T; Teter B; Ubeda O; Rostaing P; Triller A; Salem N; Ashe KH; Frautschy SA; Cole GM
Neuron; 2004 Sep; 43(5):633-45. PubMed ID: 15339646
[TBL] [Abstract][Full Text] [Related]
4. Endogenous conversion of omega-6 into omega-3 fatty acids improves neuropathology in an animal model of Alzheimer's disease.
Lebbadi M; Julien C; Phivilay A; Tremblay C; Emond V; Kang JX; Calon F
J Alzheimers Dis; 2011; 27(4):853-69. PubMed ID: 21914946
[TBL] [Abstract][Full Text] [Related]
5. High dietary consumption of trans fatty acids decreases brain docosahexaenoic acid but does not alter amyloid-beta and tau pathologies in the 3xTg-AD model of Alzheimer's disease.
Phivilay A; Julien C; Tremblay C; Berthiaume L; Julien P; Giguère Y; Calon F
Neuroscience; 2009 Mar; 159(1):296-307. PubMed ID: 19135506
[TBL] [Abstract][Full Text] [Related]
6. Dietary DHA supplementation causes selective changes in phospholipids from different brain regions in both wild type mice and the Tg2576 mouse model of Alzheimer's disease.
Bascoul-Colombo C; Guschina IA; Maskrey BH; Good M; O'Donnell VB; Harwood JL
Biochim Biophys Acta; 2016 Jun; 1861(6):524-37. PubMed ID: 26968097
[TBL] [Abstract][Full Text] [Related]
7. N-methyl-D-aspartate receptor subunit NR2A and NR2B messenger RNA levels are altered in the hippocampus and entorhinal cortex in Alzheimer's disease.
Bi H; Sze CI
J Neurol Sci; 2002 Aug; 200(1-2):11-8. PubMed ID: 12127670
[TBL] [Abstract][Full Text] [Related]
8. A diet high in omega-3 fatty acids does not improve or protect cognitive performance in Alzheimer's transgenic mice.
Arendash GW; Jensen MT; Salem N; Hussein N; Cracchiolo J; Dickson A; Leighty R; Potter H
Neuroscience; 2007 Oct; 149(2):286-302. PubMed ID: 17904756
[TBL] [Abstract][Full Text] [Related]
9. Time-dependent effect of oligomeric amyloid-β (1-42)-induced hippocampal neurodegeneration in rat model of Alzheimer's disease.
Karthick C; Nithiyanandan S; Essa MM; Guillemin GJ; Jayachandran SK; Anusuyadevi M
Neurol Res; 2019 Feb; 41(2):139-150. PubMed ID: 30453864
[TBL] [Abstract][Full Text] [Related]
10. Calpastatin levels affect calpain activation and calpain proteolytic activity in APP transgenic mouse model of Alzheimer's disease.
Vaisid T; Kosower NS; Katzav A; Chapman J; Barnoy S
Neurochem Int; 2007; 51(6-7):391-7. PubMed ID: 17513017
[TBL] [Abstract][Full Text] [Related]
11. Omega-3 fatty acid docosahexaenoic acid increases SorLA/LR11, a sorting protein with reduced expression in sporadic Alzheimer's disease (AD): relevance to AD prevention.
Ma QL; Teter B; Ubeda OJ; Morihara T; Dhoot D; Nyby MD; Tuck ML; Frautschy SA; Cole GM
J Neurosci; 2007 Dec; 27(52):14299-307. PubMed ID: 18160637
[TBL] [Abstract][Full Text] [Related]
12. Differences Between Tg2576 and Wild Type Mice in the NMDA Receptor-Nitric Oxide Pathway After Prolonged Application of a Diet High in Advanced Glycation End Products.
Kristofikova Z; Ricny J; Sirova J; Ripova D; Lubitz I; Schnaider-Beeri M
Neurochem Res; 2015 Aug; 40(8):1709-18. PubMed ID: 26189181
[TBL] [Abstract][Full Text] [Related]
13. Impact of different saturated fatty acid, polyunsaturated fatty acid and cholesterol containing diets on beta-amyloid accumulation in APP/PS1 transgenic mice.
Oksman M; Iivonen H; Hogyes E; Amtul Z; Penke B; Leenders I; Broersen L; Lütjohann D; Hartmann T; Tanila H
Neurobiol Dis; 2006 Sep; 23(3):563-72. PubMed ID: 16765602
[TBL] [Abstract][Full Text] [Related]
14. Reduced blood-brain barrier expression of fatty acid-binding protein 5 is associated with increased vulnerability of APP/PS1 mice to cognitive deficits from low omega-3 fatty acid diets.
Pan Y; Choy KHC; Marriott PJ; Chai SY; Scanlon MJ; Porter CJH; Short JL; Nicolazzo JA
J Neurochem; 2018 Jan; 144(1):81-92. PubMed ID: 29105065
[TBL] [Abstract][Full Text] [Related]
15. Membrane lipid modifications and therapeutic effects mediated by hydroxydocosahexaenoic acid on Alzheimer's disease.
Torres M; Price SL; Fiol-Deroque MA; Marcilla-Etxenike A; Ahyayauch H; Barceló-Coblijn G; Terés S; Katsouri L; Ordinas M; López DJ; Ibarguren M; Goñi FM; Busquets X; Vitorica J; Sastre M; Escribá PV
Biochim Biophys Acta; 2014 Jun; 1838(6):1680-92. PubMed ID: 24374316
[TBL] [Abstract][Full Text] [Related]
16. Early changes in hippocampal Eph receptors precede the onset of memory decline in mouse models of Alzheimer's disease.
Simón AM; de Maturana RL; Ricobaraza A; Escribano L; Schiapparelli L; Cuadrado-Tejedor M; Pérez-Mediavilla A; Avila J; Del Río J; Frechilla D
J Alzheimers Dis; 2009; 17(4):773-86. PubMed ID: 19542617
[TBL] [Abstract][Full Text] [Related]
17. Xanthoceraside modulates NR2B-containing NMDA receptors at synapses and rescues learning-memory deficits in APP/PS1 transgenic mice.
Zhu L; Yang L; Zhao X; Liu D; Guo X; Liu P; Chi T; Ji X; Zou L
Psychopharmacology (Berl); 2018 Jan; 235(1):337-349. PubMed ID: 29124300
[TBL] [Abstract][Full Text] [Related]
18. Effect of trichostatin A on gelsolin levels, proteolysis of amyloid precursor protein, and amyloid beta-protein load in the brain of transgenic mouse model of Alzheimer's disease.
Yang W; Chauhan A; Wegiel J; Kuchna I; Gu F; Chauhan V
Curr Alzheimer Res; 2014; 11(10):1002-11. PubMed ID: 25387339
[TBL] [Abstract][Full Text] [Related]
19. Impaired Src signaling and post-synaptic actin polymerization in Alzheimer's disease mice hippocampus--linking NMDA receptors and the reelin pathway.
Mota SI; Ferreira IL; Valero J; Ferreiro E; Carvalho AL; Oliveira CR; Rego AC
Exp Neurol; 2014 Nov; 261():698-709. PubMed ID: 25128699
[TBL] [Abstract][Full Text] [Related]
20. Complex alteration of NMDA receptors in transgenic Huntington's disease mouse brain: analysis of mRNA and protein expression, plasma membrane association, interacting proteins, and phosphorylation.
Luthi-Carter R; Apostol BL; Dunah AW; DeJohn MM; Farrell LA; Bates GP; Young AB; Standaert DG; Thompson LM; Cha JH
Neurobiol Dis; 2003 Dec; 14(3):624-36. PubMed ID: 14678777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
